News | Congenital Heart

A multi-center study done in the United States and Canada may have global applicability for families with children afflicted with cardiomyopathy. Findings from this large National Institutes of Health (NIH) study, which have important implications in how to treat two types of dilated cardiomyopathy in children, have been published in Circulation Heart Failure, an official journal of the American Heart Association. The paper, representing findings from nearly 100 pediatric cardiology centers, is titled “Differences in Presentation and Outcomes Between Children with Familial Dilated Cardiomyopathy and Children With Idiopathic Dilated Cardiomyopathy: A Report From the Pediatric Cardiomyopathy Registry Study Group.”

Home April 04, 2017
Home
News | Atherectomy Devices

Cardiovascular Systems Inc., in partnership with the Cardiovascular Research Foundation (CRF), announced the first subject enrolled in its ECLIPSE clinical trial. The subject was treated by Richard Shlofmitz, M.D., interventional cardiologist and director of the Department of Cardiology at St. Francis Hospital, Roslyn, N.Y. Shlofmitz also treated subjects in CSI’s ORBIT II and COAST clinical studies.

Home April 04, 2017
Home
News | Cardiovascular Ultrasound

The American Society of Echocardiography (ASE) and the European Association of Cardiovascular Imaging (EACVI) have released a new joint document updating guidance for how best to use echocardiography to assess the growing number of patients with aortic stenosis (AS). The paper, Recommendations on the Echocardiographic Assessment of Aortic Valve Stenosis: A Focused Update from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE), will appear in the April issue of the Journal of the American Society of Echocardiography (JASE).

Home April 03, 2017
Home
News | Clinical Decision Support

The newest release of American College of Radiology (ACR) Appropriateness Criteria covers 230 topics with more than 1,100 clinical indications.

Home April 03, 2017
Home
News | Pharmaceuticals

There is no evidence that adding a new cholesterol-lowering drug to treatment with a statin causes memory loss or other problems with cognition or thinking, according to findings from the EBBINGHAUS study. The research from the largest, most rigorously designed study to address this issue to date was presented at the American College of Cardiology’s 66th Annual Scientific Session, March 17-19 in Washington, D.C.

Home April 03, 2017
Home
News | Cath Lab

https://www.dicardiology.com/content/new-protocol-henry-ford-hospital-dramatically-increases-heart-attack-survival-ratesThe influence of cardiac arrest and cardiogenic shock on outcomes of patients with ST-elevation myocardial infarction (STEMI) has not been completely studied. Researchers at the Minneapolis Heart Institute Foundation (MHIF) conducted a study to determine the incidence, characteristics and outcomes of STEMI complicated by cardiac arrest with or without cardiogenic shock.

Home April 03, 2017
Home
News | Ventricular Assist Devices (VAD)

Hospitals can dramatically increase heart attack survival rates in patients suffering cardiogenic shock by providing rapid hemodynamic support before treating the cause of a heart attack, according to a new analysis that included more than 15,000 patients across the United States.

Home April 03, 2017
Home
News | Cath Lab

A new meta-analysis further supports the ability of RenalGuard Therapy to significantly reduce the incidence of acute kidney injury associated with cardiovascular interventional procedures compared to other methods of urine volume expansion. Moreover, findings from the analysis show the use of RenalGuard Therapy to be further associated with reduced risk of mortality, major adverse cardiovascular events and the need for post-procedure dialysis.

Home April 03, 2017
Home
Videos | ACC

DAIC Editor Dave Fornell takes a tour of some of the interesting new technologies from the vendor booths on the expo ...

Home April 03, 2017
Home
tryton side branch stent, dedicated coronary side branch stent
Feature | Dave Fornell

April 3, 2017 — Here is the list of the top 25 most popular pieces of content on the Diagnostic and Interventional ...

Home April 03, 2017
Home
News | PET-MRI

March 31, 2017 — Northwestern Memorial Hospital is now home to the Chicago area's first combined magnetic resonance (MRI ...

Home March 31, 2017
Home
News | Stents Bifurcation

Tryton Medical Inc. recently announced that the first U.S. commercial case using the Tryton Side Branch Stent was completed at New York-Presbyterian Hospital/Columbia University Medical Center in New York City. The device was used to treat a coronary bifurcation lesion involving a large side branch (appropriate for a ≥2.5mm stent) in a procedure performed by Martin Leon, M.D., director of the Center for Interventional Vascular Therapy, and Ajay Kirtane, M.D., SM, director of the Cardiac Catheterization Laboratory.

Home March 31, 2017
Home
News | Vascular Access

The U.S. Food and Drug Administration (FDA) announced it has initiated a Class I recall of the Merit Prelude Short Sheath Introducer, warning that a manufacturing defect may cause the tip to separate from the sheath during the separation procedure. The agency said that if this occurs, the tip could enter the patient’s bloodstream. This may result in prolonged procedure times, additional surgery to remove the tip from the patient, blood clots, internal tears and perforation to arteries or veins, excessive bleeding and death.

Home March 31, 2017
Home
Videos | Stents Bioresorbable

Stephen Ellis, M.D., professor of medicine and director of interventional cardiology at Cleveland Clinic, discusses the ...

Home March 30, 2017
Home
News | Radiation Dose Management

The Connecticut Hospital Association (CHA) and Bayer announced an alliance to establish the United States' first-ever statewide radiation dose management repository for patients undergoing certain radiological procedures. The repository will use Bayer’s Radimetrics, a radiation and contrast dose management and analytics tool which provides clinicians with data needed for them to help ensure their patients receive the lowest radiation dosage necessary. The goal is for clinicians to be able to share the data in order to benchmark radiation exposure.

Home March 30, 2017
Home
Subscribe Now